Aasa-Chapman MM - Search Results

1

Humoral immunity to HIV-1: neutralisation and antibody effector functions.

Willey S, Aasa-Chapman MM. Willey S, et al. Among authors: aasa chapman mm. Trends Microbiol. 2008 Dec;16(12):596-604. doi: 10.1016/j.tim.2008.08.008. Epub 2008 Oct 27. Trends Microbiol. 2008. PMID: 18964020 Review.

2

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection.

Willey S, Aasa-Chapman MM, O'Farrell S, Pellegrino P, Williams I, Weiss RA, Neil SJ. Willey S, et al. Among authors: aasa chapman mm. Retrovirology. 2011 Mar 14;8:16. doi: 10.1186/1742-4690-8-16. Retrovirology. 2011. PMID: 21401915 Free PMC article.

3

Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection.

Aasa-Chapman MM, Holuigue S, Aubin K, Wong M, Jones NA, Cornforth D, Pellegrino P, Newton P, Williams I, Borrow P, McKnight A. Aasa-Chapman MM, et al. J Virol. 2005 Mar;79(5):2823-30. doi: 10.1128/JVI.79.5.2823-2830.2005. J Virol. 2005. PMID: 15709001 Free PMC article.

4

Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.

Forsman A, Beirnaert E, Aasa-Chapman MM, Hoorelbeke B, Hijazi K, Koh W, Tack V, Szynol A, Kelly C, McKnight A, Verrips T, de Haard H, Weiss RA. Forsman A, et al. Among authors: aasa chapman mm. J Virol. 2008 Dec;82(24):12069-81. doi: 10.1128/JVI.01379-08. Epub 2008 Oct 8. J Virol. 2008. PMID: 18842738 Free PMC article.

5

Novel subtype C human immunodeficiency virus type 1 envelopes cloned directly from plasma: coreceptor usage and neutralization phenotypes.

Koh WW, Forsman A, Hué S, van der Velden GJ, Yirrell DL, McKnight A, Weiss RA, Aasa-Chapman MM. Koh WW, et al. Among authors: aasa chapman mm. J Gen Virol. 2010 Sep;91(Pt 9):2374-80. doi: 10.1099/vir.0.022228-0. Epub 2010 May 19. J Gen Virol. 2010. PMID: 20484560

6

Clade specific neutralising vaccines for HIV: an appropriate target?

McKnight A, Aasa-Chapman MM. McKnight A, et al. Curr HIV Res. 2007 Nov;5(6):554-60. doi: 10.2174/157016207782418524. Curr HIV Res. 2007. PMID: 18045111 Review.

7

In vivo emergence of HIV-1 highly sensitive to neutralizing antibodies.

Aasa-Chapman MM, Cheney KM, Hué S, Forsman A, O'Farrell S, Pellegrino P, Williams I, McKnight Á. Aasa-Chapman MM, et al. PLoS One. 2011;6(8):e23961. doi: 10.1371/journal.pone.0023961. Epub 2011 Aug 24. PLoS One. 2011. PMID: 21887353 Free PMC article.

8

Mapping the immune response to the outer domain of a human immunodeficiency virus-1 clade C gp120.

Chen H, Xu X, Lin HH, Chen SH, Forsman A, Aasa-Chapman M, Jones IM. Chen H, et al. J Gen Virol. 2008 Oct;89(Pt 10):2597-2604. doi: 10.1099/vir.0.2008/003491-0. J Gen Virol. 2008. PMID: 18796729 Free PMC article.

9

Primary CCR5 only using HIV-1 isolates does not accurately represent the in vivo replicating quasi-species.

Aasa-Chapman MM, Aubin K, Williams I, McKnight A. Aasa-Chapman MM, et al. Virology. 2006 Aug 1;351(2):489-96. doi: 10.1016/j.virol.2006.04.002. Epub 2006 May 19. Virology. 2006. PMID: 16712896 Free article.

10

Development of the antibody response in acute HIV-1 infection.

Aasa-Chapman MM, Hayman A, Newton P, Cornforth D, Williams I, Borrow P, Balfe P, McKnight A. Aasa-Chapman MM, et al. AIDS. 2004 Feb 20;18(3):371-81. doi: 10.1097/00002030-200402200-00002. AIDS. 2004. PMID: 15090788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page